

Qualy #121 - The “art” of longevity: the challenge of preventative medicine and understanding risk
Mar 3, 2020
Dive into the intricacies of preventative medicine and discover the challenges faced in cardiovascular health. Learn how personalized evaluations can improve patient outcomes while navigating the complexities of disease risk assessment. The discussion reveals the shortcomings of traditional clinical trials and the importance of evidence-informed approaches. Gain insights into the art of medicine, emphasizing patient engagement and the nuanced balance between scientific knowledge and compassionate care.
AI Snips
Chapters
Transcript
Episode notes
The Personalized Prevention Paradox
- Doctors face a dilemma: how aggressive should they be in preventative care?
- Clinical trials, focusing on averages, don't offer clear guidance for individual patient needs.
The Prevention Trial Problem
- Preventative medicine trials are difficult due to their long timeframes.
- Short-term clinical trials favor immediate results over long-term prevention strategies.
Evolving Practices in Preventative Cardiology
- Dr. Weiss' approach to preventative cardiology has evolved over time, incorporating new factors like LP(a) and coronary calcium scans.
- He acknowledges the lack of robust evidence-based support for some of these newer practices.